Home / News / DarioHealth Expands Hypertension Program Through Solera Health Network, More Than Doubling Addressable Market 

DarioHealth Expands Hypertension Program Through Solera Health Network, More Than Doubling Addressable Market 

Overview 

  • Solera Health has expanded DarioHealth’s digital health offerings on its platform to include a broader hypertension program.  
  • The expanded program covers members from pre-hypertension through Stage 2 hypertension, more than doubling Dario’s addressable market within the Solera network.  
  • The agreement strengthens Dario’s outcomes-based growth strategy through Solera’s payer and employer relationships.  

The News 

DarioHealth announced that Solera Health has expanded its digital health offerings on the platform to include Dario’s broader hypertension program. The program now covers members across the hypertension continuum, from pre-hypertension through Stage 2 hypertension, more than doubling Dario’s addressable population within Solera’s network. 

The expansion strengthens Dario’s position as an in-network digital health partner and creates additional opportunities for growth through Solera’s relationships with employers, health plans, and other payers. Dario’s AI-powered engagement platform, connected devices, and personalized coaching support sustained behavior change through a year-long care model, with revenue increasingly tied to engagement and clinical outcomes. 

Industry Perspective 

With hypertension affecting nearly half of U.S. adults, health plans and employers are increasingly seeking scalable solutions that support early intervention and long-term management. Expanding care across the full hypertension spectrum can help address risk earlier while improving outcomes and reducing downstream healthcare costs. 

Strategic Impact 

The expanded partnership strengthens DarioHealth’s channel-led growth strategy and broadens its reach into a large, predominantly non-diabetic population. By leveraging Solera’s established payer and employer network and aligning revenue with engagement and clinical outcomes, Dario can pursue more predictable, recurring growth while expanding its role in value-based cardiometabolic care.  

Source: PRnewswire

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *